Midcap stocks managed to outperform the frontline indices, with Nifty Midcap 50 trading 0.56 percent higher from the previous close Read More Midcap stocks managed to outperform the frontline indices, with Nifty Midcap 50 trading 0.56 percent higher from the… Read More »Mid-day Mood | Market swings gains and losses, Fed chair speech eyed for cues
Midcap stocks managed to outperform the frontline indices, with Nifty Midcap 50 trading 0.56 percent higher from the previous close Read More Midcap stocks managed to outperform the frontline indices, with Nifty Midcap 50 trading 0.56 percent higher from the… Read More »Mid-day Mood | Market swings between gains and losses, Fed chair speech eyed for cues
The US FDA conducted a Good Manufacturing Practices (GMP) Inspection of Piramal Pharma Limited#39;s Bethlehem facility from 18th September 2023 to 27th September 2023. Read More The US FDA conducted a Good Manufacturing Practices (GMP) Inspection of Piramal Pharma Limited#39;s… Read More »Piramal Pharma up almost 4% as US FDA closes inspection at Bethlehem plant
NULL Read More NULL NULL Moneycontrol Latest News Read More NULL
NULL Read More NULL NULL Moneycontrol Latest News Read More NULL
NULL Read More NULL NULL Moneycontrol Latest News Read More NULL
NULL Read More NULL NULL Moneycontrol Latest News Read More NULL
NULL Read More NULL NULL Moneycontrol Latest News Read More NULL
The current liabilities of the Shree Renuka Sugars and its subsidiaries exceed its current assets by Rs 2,452.1 crore. Read More The current liabilities of the Shree Renuka Sugars and its subsidiaries exceed its current assets by Rs 2,452.1 crore.… Read More »Shree Renuka Sugars slip 3% as Q2 loss widens to Rs 206 crore
The Nazara Technologies stock has given a return of 42.68 percent over the last six months. The benchmark Nifty50 index has given a return of 6.45 percent over the same duration. Read More The Nazara Technologies stock has given a… Read More »Nazara Tech Q2 net profit jumps 53.3% to Rs 24.2 crore; stock rises 1%
English 
हिन्दी